Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
The company uses iPS cells to develop treatments for diseases relating to the kidney
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
The newly setup entity, Emcutix Biopharmaceuticals Limited, plans to significantly expand Emcure’s offerings
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B cells present in autoimmune diseases such as lupus
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
Subscribe To Our Newsletter & Stay Updated